Top Stories

• 

  Celebs Focus On PI Fees In Daily Mail Privacy Trial Closing

  By Ronan Barnard

  Daily Mail journalists "habitually commissioned" private investigators to procure information using unlawful met...(read more)

• 

  Coca-Cola Wins 'Creations' UK TM Clash With Robinsons

  By Jamie Lennox

  Coca-Cola has beaten a challenge to its "Creations" trademark applications in the U.K., proving that shoppers wo...(read more)

• DLA Piper's London Office Managing Partner To Leave Firm

  By Ashish Sareen

  The managing partner of DLA Piper's office in London is set to depart as a partnership vote looms on changing the structure of the firm.

• SFO Backs Conviction After Finding Undisclosed Material

  By Christopher Crosby

  The Serious Fraud Office said Friday that it has uncovered material that it should have disclosed to a defendant before their trial but that the evidence, found in a historical review of cases, did not undermine their conviction.

• Oligarch Fights To Reopen Tossed $14B Asset-Stripping Claim

  By William Janes

  Imprisoned oligarch Ziyavudin Magomedov asked a London appeals court on Friday to revive his $14 billion claim that he was the victim of a Russian state-led conspiracy to strip his assets in two major port operators.

• Lloyds Banking Group IT Glitch Exposed 448K Accounts

  By Tom Fish

  Almost half a million Lloyds Banking Group customers had their personal data exposed in March because of a software failure, a parliamentary group said in a report published Friday, prompting fresh scrutiny from lawmakers over the resilience of Britain's online banking system.

• Crown Court Backlog Tops 80K As Gov't Promises Action

  By Marialuisa Taddia

  The Ministry of Justice has said the number of cases awaiting trial at Crown Courts in England and Wales has climbed above 80,000 for the first time as the government said it would pull "every lever" to cut the growing backlog.

• Novartis To Buy US Biotech In Up-To-$2B Allergy Drug Deal

  By Najiyya Budaly

  Swiss pharmaceutical giant Novartis AG said Friday that it will buy Excellergy, a U.S. biotechnology company, for up to $2 billion as it seeks access to a therapy to combat allergic reactions.

• SRA Says Dentons AML Case Needs Fresh Tribunal

  By Ronan Barnard

  The Solicitors Regulation Authority said Thursday that the Court of Appeal should uphold a ruling that a regulatory tribunal should rehear allegations that Dentons had breached anti-money laundering regulations, arguing that the tribunal had misdirected itself.

• UK Hits Crypto Network Tied To Cambodia Scam Hub

  By Christopher Crosby

  The U.K. sanctioned on Thursday a "key lieutenant" to the billionaire businessman behind Cambodia's scam centers as well as a major crypto marketplace catering to fraudsters in the latest crackdown on online threats that target Britons.

• Addison Lee Drivers Edge Closer To £20M Worker Status Win

  By Jamie Lennox

  Hundreds of Addison Lee taxi drivers have moved closer to a possible £20 million ($26.7 million) worker status payout after a tribunal largely adopted their way of deciding compensation, lawyers for the claimants said Thursday.

• Italy Seizes €20M Tied To Fraud Against Ursula Andress

  By Eddie Beaver

  Italian police said Thursday that they have seized approximately €20 million ($23 million) worth of assets in Florence, suspected to be the proceeds of money laundering that allegedly targeted James Bond actor Ursula Andress.

• FCA To Use AI To Spot Consumer Harm Faster In New Plan

  By Alex Davidson

  The Financial Conduct Authority set out plans on Thursday to use artificial intelligence as a regulatory tool to authorize businesses and detect harm faster in its annual work program.

• EU Adopts Landmark Anti-Corruption Law

  By Christopher Crosby

  European Union lawmakers passed a new set of bloc-wide anti-corruption rules on Thursday that will streamline legal definitions and set out penalties for bribery, misappropriation and economic crimes as the bloc seeks to crack down on corruption across borders.